The trucks left the Memphis factory carrying the vaccine developed by Moderna Inc. and the National Institutes of Health. The much-needed shots are expected to be handed in starting Monday, just three days after the Food and Drug Administration approves their emergency rollout.
Also on Sunday, a committee of experts began to consider who should stand up next for early doses of the Moderna vaccine and a similar vaccine from Pfizer Inc. and BioNTech in Germany. Pfizer’s shots were first sent out a week ago and used the next day to kick off the country’s largest vaccination campaign.
Public health experts say the shots – and others in the pipeline – are the only way to stop a virus spreading wildly. Nationwide, an average of more than 219,000 people a day test the virus, which has killed at least 314,000 in the United States and more than 1.7 million people worldwide.
The Pfizer and Moderna recordings that have been shipped to date and will be released in the next few weeks will almost all be given to health professionals and residents of nursing homes, based on the recommendations of the Advisory Committee on Vaccination Practices.
There won’t be enough shots for the general population by spring, so cans will be rationed for at least the next few months. President-elect Joe Biden promised earlier this month to hand out 100 million vaccine doses in his first 100 days in office, and his surgeon general candidate said Sunday that it was still a realistic goal.
But Vivek Murthy said on NBC’s Meet the Press it was more realistic to believe it could be midsummer or early fall before coronavirus vaccines are available to the general population rather than late spring. Murthy said Biden’s team is working to make the footage available to those at lower risk by late spring, but requires “everything to go according to plan.”
“I think it’s more realistic to assume that it could be closer to midsummer or early fall when this vaccine hits the general population,” Murthy said. “So we want to be optimistic, but we want to be careful.” also.”
Meanwhile, Trump’s surgeon-general Jerome Adams defended the government’s handling of the Pfizer vaccine on Sunday for “miscommunication” with the Army on Saturday, the day after the Army’s general charge of receiving COVID-19 vaccines in the US States had apologized about the number of doses to be given At least a dozen states said they would receive a smaller second shipment of the Pfizer vaccine than they had previously been notified.
General Gustave Perna told reporters on a telephone conference that he had made mistakes in listing the number of cans he believed were ready.
But Adams said on CBS ‘Face the Nation that “the numbers will go up and down”.
“It was absolutely not bad planning,” he said. “There is what we plan. There is what we actually assign. There is what is delivered, and then there is what is actually put into the arms of the people.”
Adams, who is Black, said he understood that suspicion of the medical community and vaccine among blacks “comes from a real place,” the mistreatment of color communities. He cited the decades-long Tuskegee experiment in Alabama that black men were with, leaving syphilis untreated so the disease could be studied.
He also said that because of their legal status, immigrants in the United States should not be denied the vaccine because “it is not ethical to deny these people”.
Expert panel members tend to put “critical workers” next in line, as people such as bus drivers, grocery store clerks, and others are the most likely to be infected. However, other experts say that it should be people 65 and over alongside people with certain conditions, because these are the Americans who die at the highest rate.
The expert panel’s advice is almost always endorsed by the United States Centers for Disease Control and Prevention. Regardless of what the CDC says, it will vary from state to state, as different health departments have different ideas about who should be closer to the top of the line.
Both the Moderna vaccine and the Pfizer BioNTech shot require two doses several weeks apart. The second dose must be from the same company as the first. Both vaccines appeared to be safe and highly protective in large, ongoing studies.
This story was published by a wire agency feed with no changes to the text. Only the heading was changed.